Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AtriCure (ATRC) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for AtriCure (ATRC) over the last 17 years, with Q3 2025 value amounting to $32.9 million.

  • AtriCure's Cost of Revenue rose 1311.95% to $32.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $130.2 million, marking a year-over-year increase of 1541.03%. This contributed to the annual value of $117.8 million for FY2024, which is 1912.31% up from last year.
  • As of Q3 2025, AtriCure's Cost of Revenue stood at $32.9 million, which was up 1311.95% from $34.7 million recorded in Q2 2025.
  • AtriCure's Cost of Revenue's 5-year high stood at $34.7 million during Q2 2025, with a 5-year trough of $14.7 million in Q1 2021.
  • Moreover, its 5-year median value for Cost of Revenue was $23.9 million (2023), whereas its average is $24.6 million.
  • The largest annual percentage gain for AtriCure's Cost of Revenue in the last 5 years was 3134.4% (2021), contrasted with its biggest fall of 274.74% (2021).
  • Quarter analysis of 5 years shows AtriCure's Cost of Revenue stood at $18.2 million in 2021, then rose by 25.89% to $22.9 million in 2022, then increased by 16.64% to $26.7 million in 2023, then increased by 18.45% to $31.7 million in 2024, then increased by 4.04% to $32.9 million in 2025.
  • Its Cost of Revenue was $32.9 million in Q3 2025, compared to $34.7 million in Q2 2025 and $31.0 million in Q1 2025.